Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

OPM- MEG in Non-immune And iMmune-medIated Neurological Disease

NCT: NCT07689682 · ACTIVE_NOT_RECRUITING

NCT IDNCT07689682
StatusACTIVE_NOT_RECRUITING
Start Date2026-05-15
Completion2034-09-15
SponsorAston University (OTHER)
First posted
Last updated

Brief Summary

Over the past 20 years, doctors have gotten much better at spotting and treating brain conditions caused by the immune system attacking the body. These include illnesses like autoimmune encephalitis, ADEM, and multiple sclerosis. But even with better treatments, many patients-especially children-still struggle with long-term problems. Standard brain scans and tests often miss important issues like memory problems, emotional difficulties, trouble sleeping, and challenges with social behaviour. Early research using a special brain imaging technique (called MEG) has shown changes in brain networks that seem to be linked to poor memory. This study will use a new, advanced version of MEG that works even with very young children (as young as 2 years old). The goal is to better understand how these brain conditions affect children, compare them with other types of brain illness, and eventually use this technology to help predict outcomes and discover new ways to track brain health.

Frequently Asked Questions

What is OPM- MEG in Non-immune And iMmune-medIated Neurological Disease?

OPM- MEG in Non-immune And iMmune-medIated Neurological Disease is a clinical trial registered under NCT07689682. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07689682?

The current status of NCT07689682 (OPM- MEG in Non-immune And iMmune-medIated Neurological Disease) is: ACTIVE_NOT_RECRUITING.

When did OPM- MEG in Non-immune And iMmune-medIated Neurological Disease start?

OPM- MEG in Non-immune And iMmune-medIated Neurological Disease started on 2026-05-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.